Fresh off of a European approval for a subcutaneous version of Saphnelo, AstraZeneca is doubling down on the benefits of the ...
CINCINNATI (WKRC) — As summer draws to a close, AstraZeneca has introduced a new way to fight the flu with the launch of FluMist Home, the first-ever home-administered flu vaccine. This innovative ...
Pharma company AstraZeneca has publicly released preclinical data from more than 50 of its medicines in order to find new drug combinations for cancer treatments. The data AstraZeneca released will be ...
AstraZeneca's ambitious $80 billion revenue goal by 2030 hinges on oncology growth and successful new drug launches, but faces patent expiries and fierce competition. While current financials and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback